Published in J Neurosci on June 14, 2006
Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol (2010) 4.77
Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev (2010) 4.59
mGluR5 has a critical role in inhibitory learning. J Neurosci (2009) 1.76
A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum Mol Genet (2009) 1.71
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology (2010) 1.51
Metabotropic glutamate receptor 7 modulates the rewarding effects of cocaine in rats: involvement of a ventral pallidal GABAergic mechanism. Neuropsychopharmacology (2009) 1.00
The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Neuropharmacology (2007) 0.97
Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7. J Biol Chem (2012) 0.96
Genome-wide association study of personality traits in bipolar patients. Psychiatr Genet (2011) 0.94
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther (2014) 0.92
Allosteric modulation of metabotropic glutamate receptors. Adv Pharmacol (2011) 0.91
Characterization of a commonly used mouse model of SMA reveals increased seizure susceptibility and heightened fear response in FVB/N mice. Neurobiol Dis (2011) 0.89
The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plast (2007) 0.89
Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082. Pharmacol Biochem Behav (2008) 0.88
Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol (2014) 0.86
Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol (2012) 0.85
Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice. Neuropharmacology (2012) 0.84
Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior. J Biol Chem (2014) 0.82
Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample. Behav Brain Funct (2013) 0.82
Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes. Transl Psychiatry (2016) 0.81
Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence. Neuropharmacology (2012) 0.79
Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus. J Neurosci (2015) 0.78
Nxf7 deficiency impairs social exploration and spatio-cognitive abilities as well as hippocampal synaptic plasticity in mice. Front Behav Neurosci (2015) 0.77
Metabotropic Glutamate Receptor Subtype 7 in the Bed Nucleus of the Stria Terminalis is Essential for Intermale Aggression. Neuropsychopharmacology (2015) 0.76
Severe Hypoxia: Consequences to Neural Stem Cells and Neurons. J Neurol Res (2011) 0.76
Neonatal amphetamine exposure and hippocampus-mediated behaviors. Neurobiol Learn Mem (2009) 0.76
Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications. Curr Neuropharmacol (2016) 0.75
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia. Mol Brain (2017) 0.75
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence. CNS Neurol Disord Drug Targets (2015) 0.75
Synthesis and evaluation of [11C]MMPIP as a potential radioligand for imaging of metabotropic glutamate 7 receptor in the brain. EJNMMI Res (2013) 0.75
Functional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines. Int J Neuropsychopharmacol (2015) 0.75
The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies. Curr Neuropharmacol (2016) 0.75
Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain. Neurobiol Stress (2015) 0.75
Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell (2006) 5.51
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A (2011) 4.91
Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci (2004) 3.61
Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron (2006) 2.53
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2008) 2.52
Psychobiotics: a novel class of psychotropic. Biol Psychiatry (2013) 2.46
gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science (2009) 2.43
Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J (2007) 2.39
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J (2010) 2.26
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem (2005) 2.03
Prediction error governs pharmacologically induced amnesia for learned fear. Science (2013) 2.00
Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology (2004) 1.72
cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci (2002) 1.71
Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol (2014) 1.71
Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet (2008) 1.69
The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J Neurosci (2008) 1.68
Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci (2004) 1.66
Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc (2012) 1.59
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A (2004) 1.58
Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci (2011) 1.57
Tyrosine phosphatases regulate AMPA receptor trafficking during metabotropic glutamate receptor-mediated long-term depression. J Neurosci (2006) 1.55
Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci (2006) 1.54
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science (2013) 1.54
Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology (2012) 1.47
Reinstatement of fear responses in human aversive conditioning. Behav Res Ther (2005) 1.44
CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. Hum Mol Genet (2003) 1.43
Evaluative conditioning in humans: a meta-analysis. Psychol Bull (2010) 1.38
Number and density of AMPA receptors in single synapses in immature cerebellum. J Neurosci (2005) 1.37
Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci (2003) 1.36
Retrieval per se is not sufficient to trigger reconsolidation of human fear memory. Neurobiol Learn Mem (2012) 1.36
A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc Natl Acad Sci U S A (2005) 1.35
Return of fear in a human differential conditioning paradigm caused by a return to the original acquistion context. Behav Res Ther (2005) 1.34
Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis (2005) 1.34
Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci (2003) 1.34
LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet (2003) 1.32
AP-1/sigma1B-adaptin mediates endosomal synaptic vesicle recycling, learning and memory. EMBO J (2010) 1.31
A review of recent developments in research and theories on human contingency learning. Q J Exp Psychol B (2002) 1.31
Affect 4.0: a free software package for implementing psychological and psychophysiological experiments. Exp Psychol (2010) 1.29
Irritable bowel syndrome: towards biomarker identification. Trends Mol Med (2009) 1.29
Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev (2011) 1.25
The microbiome: stress, health and disease. Mamm Genome (2013) 1.24
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci (2008) 1.23
Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci (2008) 1.22
The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol Psychiatry (2007) 1.20
Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice. Hum Mol Genet (2008) 1.20
Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice. Behav Brain Res (2009) 1.19
Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) (2010) 1.17
Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol (2012) 1.15
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes. Neuropsychopharmacology (2012) 1.11
Reinstatement of extinguished conditioned responses and negative stimulus valence as a pathway to return of fear in humans. Learn Mem (2004) 1.11
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl) (2012) 1.09
Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav Immun (2011) 1.09
Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. Mol Ther (2009) 1.08
The repeated confrontation with videotapes of spiders in multiple contexts attenuates renewal of fear in spider-anxious students. Behav Res Ther (2006) 1.08
The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol (2014) 1.08
Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int J Neuropsychopharmacol (2010) 1.07
Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07
Return of fear in a human differential conditioning paradigm caused by a stimulus change after extinction. Behav Res Ther (2005) 1.07
Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol (2014) 1.06
Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. J Pharmacol Exp Ther (2002) 1.06
Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1. J Neurosci (2010) 1.05
GABA(B(1)) receptor isoforms differentially mediate the acquisition and extinction of aversive taste memories. J Neurosci (2006) 1.05
Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport (2005) 1.05
Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology (2006) 1.04
Extinction, generalization, and return of fear: a critical review of renewal research in humans. Biol Psychol (2012) 1.04
Outcome and cue properties modulate blocking. Q J Exp Psychol A (2002) 1.03
The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology (2005) 1.02
Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat. J Psychopharmacol (2010) 1.02
GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent. J Pharmacol Exp Ther (2004) 1.02
Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol Ther (2012) 1.02
Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev (2011) 1.02
TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. Mol Neurobiol (2012) 1.01
Experience-dependent modification of mechanisms of long-term depression. Nat Neurosci (2006) 1.01
Sex differences in human virtual water maze performance: novel measures reveal the relative contribution of directional responding and spatial knowledge. Behav Brain Res (2009) 1.01
Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex (2009) 1.01
Differences in behavioural test battery performance between mice with hippocampal and cerebellar lesions. Behav Brain Res (2006) 1.01
Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis. J Neurosci (2005) 1.01
Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour. Stress (2010) 1.00
Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy. Hum Mol Genet (2011) 1.00
rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol Neurodegener (2013) 1.00
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol (2009) 1.00
Activity blockade increases the number of functional synapses in the hippocampus of newborn rats. Mol Cell Neurosci (2003) 1.00
TBP as a candidate gene for mental retardation in patients with subtelomeric 6q deletions. Eur J Hum Genet (2006) 1.00
Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings. Br J Pharmacol (2012) 1.00
Smoking behavior in context: where and when do people smoke? J Behav Ther Exp Psychiatry (2010) 0.99
Identification of everyday objects on the basis of silhouette and outline versions. Perception (2008) 0.99
Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl) (2006) 0.99
Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology (2009) 0.98
Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity. J Cell Mol Med (2010) 0.98
Specific roles of GABA(B(1)) receptor isoforms in cognition. Behav Brain Res (2007) 0.98
"Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol (2009) 0.97
Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J Biol Chem (2012) 0.97
Secondary task difficulty modulates forward blocking in human contingency learning. Q J Exp Psychol B (2003) 0.97
GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology (2006) 0.97
Lithium-induced effects on adult hippocampal neurogenesis are topographically segregated along the dorso-ventral axis of stressed mice. Neuropharmacology (2011) 0.97
Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci (2013) 0.97